Polycythemia

Disease

2 papers1 finding

MeSH D011086

Associations

SGLT2 inhibitors

upin humans1

1 study

SGLT2 inhibitors raise the risk of polycythemia in humans (from 2.4% to 9.7%).
“Real-world data (9,646 patients) reported an increase in polycythemia prevalence from 2.4% to 9.7%, with severe cases in 1.4% of patients.”
Reviewtype 2 diabetes mellitusn = 9,646
SGLT2 inhibitors and secondary polycythemia: a systematic review and meta-analysis of hematologic effects in patients with type 2 diabetes
European journal of clinical pharmacology13 Aug 2026

Latest

5 in 12 months

Upsala Journal of Medical SciencesYesterday

De novo development of JAK2V617F-positive polycythemia vera following allogeneic hematopoietic stem cell transplantation: a report of two rare cases

Case seriesBlood and immune system

Paper

Blood Advances7 Oct

Metformin linked to fewer clots in blood cancer and diabetes

Metformin users had lower blood clot risk than non-users, with a hazard ratio of 0.78, a measure comparing risk over time.Metformin users had lower blood clot risk than non-users, with a hazard ratio of 0.78, a measure comparing risk over time.

Cohort study of 1,153 peopleDiabetes

Paper

European Journal of Haematology1 Sep